TY - JOUR AU - Lieberman, J. A. PY - 1996 DA - 1996// TI - Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis JO - J Clin Psychiatry VL - 57 ID - Lieberman1996 ER - TY - JOUR AU - Andreasen, N. C. AU - Liu, D. AU - Ziebell, S. AU - Vora, A. AU - Ho, B. C. PY - 2013 DA - 2013// TI - Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study JO - Am J Psychiatry VL - 170 UR - https://doi.org/10.1176/appi.ajp.2013.12050674 DO - 10.1176/appi.ajp.2013.12050674 ID - Andreasen2013 ER - TY - JOUR AU - Leucht, S. AU - Tardy, M. AU - Komossa, K. AU - Heres, S. AU - Kissling, W. AU - Salanti, G. AU - Davis, J. M. PY - 2012 DA - 2012// TI - Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60239-6 DO - 10.1016/S0140-6736(12)60239-6 ID - Leucht2012 ER - TY - JOUR AU - Mojtabai, R. AU - Lavelle, J. AU - Gibson, P. J. AU - Sohler, N. L. AU - Craig, T. J. AU - Carlson, G. A. AU - Bromet, E. J. PY - 2002 DA - 2002// TI - Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996 JO - Psychiatr Serv VL - 53 UR - https://doi.org/10.1176/appi.ps.53.3.337 DO - 10.1176/appi.ps.53.3.337 ID - Mojtabai2002 ER - TY - JOUR AU - Weiden, P. J. AU - Kozma, C. AU - Grogg, A. AU - Locklear, J. PY - 2004 DA - 2004// TI - Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia JO - Psychiatr Serv VL - 55 UR - https://doi.org/10.1176/appi.ps.55.8.886 DO - 10.1176/appi.ps.55.8.886 ID - Weiden2004 ER - TY - JOUR AU - Baloush-Kleinman, V. AU - Levine, S. Z. AU - Roe, D. AU - Shnitt, D. AU - Weizman, A. AU - Poyurovsky, M. PY - 2011 DA - 2011// TI - Adherence to antipsychotic drug treatment in early-episode schizophrenia: a 6-month naturalistic follow-up study JO - Schizophr Res VL - 130 UR - https://doi.org/10.1016/j.schres.2011.04.030 DO - 10.1016/j.schres.2011.04.030 ID - Baloush-Kleinman2011 ER - TY - JOUR AU - Karow, A. AU - Czekalla, J. AU - Dittmann, R. W. AU - Schacht, A. AU - Wagner, T. AU - Lambert, M. AU - Schimmelmann, B. G. AU - Naber, D. PY - 2007 DA - 2007// TI - Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia JO - J Clin Psychiatr VL - 68 UR - https://doi.org/10.4088/JCP.v68n0110 DO - 10.4088/JCP.v68n0110 ID - Karow2007 ER - TY - JOUR AU - McCabe, R. AU - Bullenkamp, J. AU - Hansson, L. AU - Lauber, C. AU - Martinez-Leal, R. AU - Rossler, W. AU - Salize, H. J. AU - Svensson, B. AU - Torres-Gonzalez, F. AU - Brink, R. PY - 2012 DA - 2012// TI - The therapeutic relationship and adherence to antipsychotic medication in schizophrenia JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0036080 DO - 10.1371/journal.pone.0036080 ID - McCabe2012 ER - TY - JOUR AU - Moritz, S. AU - Hunsche, A. AU - Lincoln, T. M. PY - 2014 DA - 2014// TI - Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms JO - Eur Neuropsychopharmacol VL - 24 UR - https://doi.org/10.1016/j.euroneuro.2014.09.008 DO - 10.1016/j.euroneuro.2014.09.008 ID - Moritz2014 ER - TY - JOUR AU - Bhanji, N. H. AU - Chouinard, G. AU - Margolese, H. C. PY - 2004 DA - 2004// TI - A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia JO - Eur Neuropsychopharmacol VL - 14 UR - https://doi.org/10.1016/S0924-977X(03)00109-3 DO - 10.1016/S0924-977X(03)00109-3 ID - Bhanji2004 ER - TY - JOUR AU - Kishimoto, T. AU - Nitta, M. AU - Borenstein, M. AU - Kane, J. M. AU - Correll, C. U. PY - 2013 DA - 2013// TI - Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies JO - J Clin Psychiatry VL - 74 UR - https://doi.org/10.4088/JCP.13r08440 DO - 10.4088/JCP.13r08440 ID - Kishimoto2013 ER - TY - JOUR AU - Gray, J. A. AU - Roth, B. L. PY - 2007 DA - 2007// TI - The pipeline and future of drug development in schizophrenia JO - Mol Psychiatry VL - 12 UR - https://doi.org/10.1038/sj.mp.4002062 DO - 10.1038/sj.mp.4002062 ID - Gray2007 ER - TY - JOUR AU - Kim, S. W. AU - Chung, Y. C. AU - Lee, Y. H. AU - Lee, J. H. AU - Kim, S. Y. AU - Bae, K. Y. AU - Kim, J. M. AU - Shin, I. S. AU - Yoon, J. S. PY - 2012 DA - 2012// TI - Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial JO - Int Clin Psychopharmacol VL - 27 UR - https://doi.org/10.1097/YIC.0b013e328356acad DO - 10.1097/YIC.0b013e328356acad ID - Kim2012 ER - TY - JOUR AU - Suzuki, H. AU - Gen, K. AU - Inoue, Y. AU - Hibino, H. AU - Mikami, A. AU - Matsumoto, H. AU - Mikami, K. PY - 2014 DA - 2014// TI - The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial JO - Int J Psychiatry Clin Pract VL - 18 UR - https://doi.org/10.3109/13651501.2013.845218 DO - 10.3109/13651501.2013.845218 ID - Suzuki2014 ER - TY - JOUR AU - Green, M. F. AU - Barnes, T. R. AU - Danion, J. M. AU - Gallhofer, B. AU - Meltzer, H. Y. AU - Pantelis, C. PY - 2005 DA - 2005// TI - The FOCIS international survey on psychiatrists’ opinions on cognition in schizophrenia JO - Schizophr Res VL - 74 UR - https://doi.org/10.1016/j.schres.2004.05.023 DO - 10.1016/j.schres.2004.05.023 ID - Green2005 ER - TY - JOUR AU - Kaneda, Y. AU - Sumiyoshi, T. AU - Keefe, R. AU - Ishimoto, Y. AU - Numata, S. AU - Ohmori, T. PY - 2007 DA - 2007// TI - Brief assessment of cognition in schizophrenia: validation of the Japanese version JO - Psychiatry Clin Neurosci VL - 61 UR - https://doi.org/10.1111/j.1440-1819.2007.01725.x DO - 10.1111/j.1440-1819.2007.01725.x ID - Kaneda2007 ER - TY - JOUR AU - Suzuki, H. AU - Gen, K. PY - 2012 DA - 2012// TI - The influence of switching from oral risperidone to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia JO - Ther Adv Psychopharmacol VL - 2 UR - https://doi.org/10.1177/2045125311430536 DO - 10.1177/2045125311430536 ID - Suzuki2012 ER - TY - JOUR AU - Suzuki, H. AU - Gen, K. PY - 2012 DA - 2012// TI - The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia JO - Hum Psychopharmacol VL - 27 UR - https://doi.org/10.1002/hup.2249 DO - 10.1002/hup.2249 ID - Suzuki2012 ER - TY - JOUR AU - Hori, H. AU - Noguchi, H. AU - Hashimoto, R. AU - Okabe, S. AU - Saitoh, O. AU - Kunugi, H. PY - 2008 DA - 2008// TI - IQ decline and memory impairment in Japanese patients with chronic schizophrenia JO - Psychiatry Res VL - 158 UR - https://doi.org/10.1016/j.psychres.2007.11.002 DO - 10.1016/j.psychres.2007.11.002 ID - Hori2008 ER - TY - STD TI - Drug information of paliperidone palmitate. Interview form of XEPLION® Aqueous Suspension for IM Injection 7th edition [http://www.info.pmda.go.jp/go/interview/1/800155_1179409G1025_1_0http://www.info.pmda.go.jp/go/pack05_1F]. Accessed 3 Apr 2016. UR - http://www.info.pmda.go.jp/go/interview/1/800155_1179409G1025_1_005_1F ID - ref20 ER - TY - JOUR AU - Naber, D. PY - 1995 DA - 1995// TI - A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables JO - Int Clin Psychopharmacol VL - 10 ID - Naber1995 ER - TY - JOUR AU - Naber, D. AU - Moritz, S. AU - Lambert, M. AU - Pajonk, F. G. AU - Holzbach, R. AU - Mass, R. AU - Andresen, B. PY - 2001 DA - 2001// TI - Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs JO - Schizophr Res VL - 50 UR - https://doi.org/10.1016/S0920-9964(00)00166-3 DO - 10.1016/S0920-9964(00)00166-3 ID - Naber2001 ER - TY - JOUR AU - Kay, S. R. AU - Fiszbein, A. AU - Opler, L. A. PY - 1987 DA - 1987// TI - The positive and negative syndrome scale (PANSS) for schizophrenia JO - Schizophr Bull VL - 13 UR - https://doi.org/10.1093/schbul/13.2.261 DO - 10.1093/schbul/13.2.261 ID - Kay1987 ER - TY - BOOK AU - Inada, T. PY - 1996 DA - 1996// TI - Evaluation and Diagnosis of Drug-induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to its Usage PB - Seiwa Shoten CY - Tokyo ID - Inada1996 ER - TY - JOUR AU - Keefe, R. S. AU - Goldberg, T. E. AU - Harvey, P. D. AU - Gold, J. M. AU - Poe, M. P. AU - Coughenour, L. PY - 2004 DA - 2004// TI - The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery JO - Schizophr Res VL - 68 UR - https://doi.org/10.1016/j.schres.2003.09.011 DO - 10.1016/j.schres.2003.09.011 ID - Keefe2004 ER - TY - JOUR AU - Hori, H. AU - Yoshimura, R. AU - Katsuki, A. AU - Hayashi, K. AU - Ikenouchi-Sugita, A. AU - Umene-Nakano, W. AU - Nakamura, J. PY - 2012 DA - 2012// TI - The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients JO - J Psychiatr Res VL - 46 UR - https://doi.org/10.1016/j.jpsychires.2012.02.013 DO - 10.1016/j.jpsychires.2012.02.013 ID - Hori2012 ER - TY - JOUR AU - Hori, H. AU - Yoshimura, R. AU - Katsuki, A. AU - Sugita, A. I. AU - Atake, K. AU - Nakamura, J. PY - 2013 DA - 2013// TI - Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients JO - J Psychiatr Res VL - 47 UR - https://doi.org/10.1016/j.jpsychires.2013.08.024 DO - 10.1016/j.jpsychires.2013.08.024 ID - Hori2013 ER - TY - JOUR AU - Kaneda, Y. AU - Sumiyoshi, T. AU - Nakagome, K. AU - Numata, S. AU - Tanaka, T. AU - Ueoka, Y. AU - Omori, T. AU - Keefe, R. PY - 2008 DA - 2008// TI - The brief assessment of cognition in schizophrenia Japanese version (BACS-J) JO - Seishinigaku VL - 50 ID - Kaneda2008 ER - TY - JOUR AU - Watanabe, M. AU - Matsumura, H. PY - 2003 DA - 2003// TI - Reliability and validity of Subjective Well-being under Neuroleptic drug treatment Short form, Japanese version (SWNS-J) JO - Jpn J Clin Psychopharmacol VL - 6 ID - Watanabe2003 ER - TY - JOUR AU - Mishara, A. L. AU - Goldberg, T. E. PY - 2004 DA - 2004// TI - A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book JO - Biol Psychiatry VL - 55 UR - https://doi.org/10.1016/j.biopsych.2004.01.027 DO - 10.1016/j.biopsych.2004.01.027 ID - Mishara2004 ER - TY - STD TI - Sakurai H, Bies RR, Stroup ST, Keefe RS, Rajji TK, Suzuki T, et al. Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. Schizophr Bull. 2013;39(3):564–74. ID - ref31 ER - TY - JOUR AU - Uchida, H. AU - Rajji, T. K. AU - Mulsant, B. H. AU - Kapur, S. AU - Pollock, B. G. AU - Graff-Guerrero, A. AU - Menon, M. AU - Mamo, D. C. PY - 2009 DA - 2009// TI - D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia JO - J Clin Psychopharmacol VL - 29 UR - https://doi.org/10.1097/JCP.0b013e3181bf4ea3 DO - 10.1097/JCP.0b013e3181bf4ea3 ID - Uchida2009 ER - TY - JOUR AU - Woodward, N. D. AU - Purdon, S. E. AU - Meltzer, H. Y. AU - Zald, D. H. PY - 2007 DA - 2007// TI - A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects JO - Schizophr Res VL - 89 UR - https://doi.org/10.1016/j.schres.2006.08.021 DO - 10.1016/j.schres.2006.08.021 ID - Woodward2007 ER - TY - JOUR AU - Takeuchi, H. AU - Suzuki, T. AU - Remington, G. AU - Bies, R. R. AU - Abe, T. AU - Graff-Guerrero, A. AU - Watanabe, K. AU - Mimura, M. AU - Uchida, H. PY - 2013 DA - 2013// TI - Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study JO - Schizophr Bull VL - 39 UR - https://doi.org/10.1093/schbul/sbt090 DO - 10.1093/schbul/sbt090 ID - Takeuchi2013 ER - TY - JOUR AU - Ogino, S. AU - Miyamoto, S. AU - Tenjin, T. AU - Kitajima, R. AU - Ojima, K. AU - Miyake, N. AU - Funamoto, Y. AU - Arai, J. AU - Tsukahara, S. AU - Ito, Y. PY - 2011 DA - 2011// TI - Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 35 UR - https://doi.org/10.1016/j.pnpbp.2010.08.030 DO - 10.1016/j.pnpbp.2010.08.030 ID - Ogino2011 ER - TY - JOUR AU - Kitajima, R. AU - Miyamoto, S. AU - Tenjin, T. AU - Ojima, K. AU - Ogino, S. AU - Miyake, N. AU - Fujiwara, K. AU - Funamoto, Y. AU - Arai, J. AU - Tsukahara, S. PY - 2012 DA - 2012// TI - Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 36 UR - https://doi.org/10.1016/j.pnpbp.2011.11.008 DO - 10.1016/j.pnpbp.2011.11.008 ID - Kitajima2012 ER - TY - JOUR AU - Woodward, N. D. AU - Purdon, S. E. AU - Meltzer, H. Y. AU - Zald, D. H. PY - 2005 DA - 2005// TI - A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia JO - Int J Neuropsychopharmacol VL - 8 UR - https://doi.org/10.1017/S146114570500516X DO - 10.1017/S146114570500516X ID - Woodward2005 ER - TY - JOUR AU - Keefe, R. S. AU - Sweeney, J. A. AU - Gu, H. AU - Hamer, R. M. AU - Perkins, D. O. AU - McEvoy, J. P. AU - Lieberman, J. A. PY - 2007 DA - 2007// TI - Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison JO - Am J Psychiatry VL - 164 UR - https://doi.org/10.1176/ajp.2007.164.7.1061 DO - 10.1176/ajp.2007.164.7.1061 ID - Keefe2007 ER - TY - JOUR AU - Davidson, M. AU - Galderisi, S. AU - Weiser, M. AU - Werbeloff, N. AU - Fleischhacker, W. W. AU - Keefe, R. S. AU - Boter, H. AU - Keet, I. P. AU - Prelipceanu, D. AU - Rybakowski, J. K. PY - 2009 DA - 2009// TI - Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) JO - Am J Psychiatry VL - 166 UR - https://doi.org/10.1176/appi.ajp.2008.08060806 DO - 10.1176/appi.ajp.2008.08060806 ID - Davidson2009 ER - TY - JOUR AU - Purdon, S. E. AU - Jones, B. D. AU - Stip, E. AU - Labelle, A. AU - Addington, D. AU - David, S. R. AU - Breier, A. AU - Tollefson, G. D. PY - 2000 DA - 2000// TI - Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia JO - Arch Gen Psychiatry VL - 57 UR - https://doi.org/10.1001/archpsyc.57.3.249 DO - 10.1001/archpsyc.57.3.249 ID - Purdon2000 ER - TY - JOUR AU - Bervoets, C. AU - Morrens, M. AU - Vansteelandt, K. AU - Kok, F. AU - Patoul, A. AU - Halkin, V. AU - Pitsi, D. AU - Constant, E. AU - Peuskens, J. AU - Sabbe, B. PY - 2012 DA - 2012// TI - Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study JO - CNS Drugs VL - 26 UR - https://doi.org/10.1007/s40263-012-0003-4 DO - 10.1007/s40263-012-0003-4 ID - Bervoets2012 ER - TY - JOUR AU - Desamericq, G. AU - Schurhoff, F. AU - Meary, A. AU - Szoke, A. AU - Macquin-Mavier, I. AU - Bachoud-Levi, A. C. AU - Maison, P. PY - 2014 DA - 2014// TI - Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis JO - Eur J Clin Pharmacol VL - 70 UR - https://doi.org/10.1007/s00228-013-1600-y DO - 10.1007/s00228-013-1600-y ID - Desamericq2014 ER - TY - JOUR AU - Nesvag, R. AU - Hendset, M. AU - Refsum, H. AU - Tanum, L. PY - 2006 DA - 2006// TI - Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication JO - Acta Psychiatr Scand VL - 114 UR - https://doi.org/10.1111/j.1600-0447.2006.00840.x DO - 10.1111/j.1600-0447.2006.00840.x ID - Nesvag2006 ER - TY - JOUR AU - Franberg, O. AU - Marcus, M. M. AU - Svensson, T. H. PY - 2012 DA - 2012// TI - Involvement of 5-HT2A receptor and alpha2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow JO - Synapse VL - 66 UR - https://doi.org/10.1002/syn.21551 DO - 10.1002/syn.21551 ID - Franberg2012 ER - TY - JOUR AU - Stenberg, J. H. AU - Terevnikov, V. AU - Joffe, M. AU - Tiihonen, J. AU - Tchoukhine, E. AU - Burkin, M. AU - Joffe, G. PY - 2010 DA - 2010// TI - Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study JO - Int J Neuropsychopharmacol VL - 13 UR - https://doi.org/10.1017/S1461145709990897 DO - 10.1017/S1461145709990897 ID - Stenberg2010 ER - TY - STD TI - Poyurovsky M, Koren D, Gonopolsky I, Schneidman M, Fuchs C, Weizman A, A, Weizman R. Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study. Eur Neuropsychopharmacol. 2003;13(2):123–8. ID - ref46 ER - TY - JOUR AU - Sara, S. J. PY - 2009 DA - 2009// TI - The locus coeruleus and noradrenergic modulation of cognition JO - Nat Rev Neurol VL - 10 UR - https://doi.org/10.1038/nrn2573 DO - 10.1038/nrn2573 ID - Sara2009 ER - TY - JOUR AU - Sheehan, J. J. AU - Reilly, K. R. AU - Fu, D. J. AU - Alphs, L. PY - 2012 DA - 2012// TI - Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents JO - Innov Clin Neurosci VL - 9 ID - Sheehan2012 ER - TY - JOUR AU - Leucht, S. AU - Cipriani, A. AU - Spineli, L. AU - Mavridis, D. AU - Orey, D. AU - Richter, F. AU - Samara, M. AU - Barbui, C. AU - Engel, R. R. AU - Geddes, J. R. PY - 2013 DA - 2013// TI - Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60733-3 DO - 10.1016/S0140-6736(13)60733-3 ID - Leucht2013 ER - TY - JOUR AU - Reilly, J. L. AU - Harris, M. S. AU - Keshavan, M. S. AU - Sweeney, J. A. PY - 2006 DA - 2006// TI - Adverse effects of risperidone on spatial working memory in first-episode schizophrenia JO - Arch Gen Psychiatry VL - 63 UR - https://doi.org/10.1001/archpsyc.63.11.1189 DO - 10.1001/archpsyc.63.11.1189 ID - Reilly2006 ER - TY - JOUR AU - Pandina, G. AU - Lane, R. AU - Gopal, S. AU - Gassmann-Mayer, C. AU - Hough, D. AU - Remmerie, B. AU - Simpson, G. PY - 2011 DA - 2011// TI - A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 35 UR - https://doi.org/10.1016/j.pnpbp.2010.11.008 DO - 10.1016/j.pnpbp.2010.11.008 ID - Pandina2011 ER - TY - JOUR AU - Fleischhacker, W. W. AU - Gopal, S. AU - Lane, R. AU - Gassmann-Mayer, C. AU - Lim, P. AU - Hough, D. AU - Remmerie, B. AU - Eerdekens, M. PY - 2012 DA - 2012// TI - A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia JO - Int J Neuropsychopharmacol VL - 15 UR - https://doi.org/10.1017/S1461145711001076 DO - 10.1017/S1461145711001076 ID - Fleischhacker2012 ER - TY - JOUR AU - Fu, D. J. AU - Bossie, C. A. AU - Sliwa, J. K. AU - Ma, Y. W. AU - Alphs, L. PY - 2014 DA - 2014// TI - Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison JO - Int Clin Psychopharmacol VL - 29 UR - https://doi.org/10.1097/YIC.0000000000000006 DO - 10.1097/YIC.0000000000000006 ID - Fu2014 ER - TY - JOUR AU - Gross, J. J. PY - 2001 DA - 2001// TI - Emotion regulation in adulthood: Timing is everything JO - Curr Dir Psychol Sci VL - 10 UR - https://doi.org/10.1111/1467-8721.00152 DO - 10.1111/1467-8721.00152 ID - Gross2001 ER - TY - JOUR AU - Ferri, J. AU - Schmidt, J. AU - Hajcak, G. AU - Canli, T. PY - 2013 DA - 2013// TI - Neural correlates of attentional deployment within unpleasant pictures JO - Neuroimage VL - 70 UR - https://doi.org/10.1016/j.neuroimage.2012.12.030 DO - 10.1016/j.neuroimage.2012.12.030 ID - Ferri2013 ER - TY - JOUR AU - Hajcak, G. AU - MacNamara, A. AU - Foti, D. AU - Ferri, J. AU - Keil, A. PY - 2013 DA - 2013// TI - The dynamic allocation of attention to emotion: simultaneous and independent evidence from the late positive potential and steady state visual evoked potentials JO - Biol Psychol VL - 92 UR - https://doi.org/10.1016/j.biopsycho.2011.11.012 DO - 10.1016/j.biopsycho.2011.11.012 ID - Hajcak2013 ER - TY - JOUR AU - Strauss, G. P. AU - Kappenman, E. S. AU - Culbreth, A. J. AU - Catalano, L. T. AU - Ossenfort, K. L. AU - Lee, B. G. AU - Gold, J. M. PY - 2014 DA - 2014// TI - Emotion Regulation Abnormalities in Schizophrenia: Directed Attention Strategies Fail to Decrease the Neurophysiological Response to Unpleasant Stimuli JO - J Abnorm Psychol VL - 124 UR - https://doi.org/10.1037/abn0000017 DO - 10.1037/abn0000017 ID - Strauss2014 ER - TY - JOUR AU - Pazvantoglu, O. AU - Simsek, O. F. AU - Aydemir, O. AU - Sarisoy, G. AU - Boke, O. AU - Ucok, A. PY - 2014 DA - 2014// TI - Factor structure of the Subjective Well-being under Neuroleptic treatment Scale-short form in schizophrenic outpatients: five factors or only one? JO - Nord J Psychiatry VL - 68 UR - https://doi.org/10.3109/08039488.2013.807875 DO - 10.3109/08039488.2013.807875 ID - Pazvantoglu2014 ER - TY - JOUR AU - Mannaert, E. AU - Vermeulen, A. AU - Remmerie, B. AU - Bouhours, P. AU - Levron, J. C. PY - 2005 DA - 2005// TI - Pharmacokinetic profile of long-acting injectable risperidone at steady-state: comparison with oral administration JO - Encéphale VL - 31 UR - https://doi.org/10.1016/S0013-7006(05)82420-0 DO - 10.1016/S0013-7006(05)82420-0 ID - Mannaert2005 ER -